Methylation of cyclin dependent kinase inhibitor 2A (CDKN2A) promoter and subsequent gene silencing have been documented in many tumors including colon cancer and it has been associated with the CpG island methylator phenotype42. The gene discussed is CDKN2A; the disease is malignant colon neoplasm.